Alembic Pharmaceuticals informs about press release

06 Aug 2018 Evaluate

Alembic Pharmaceutical has informed about press release that the company received US Food & Drug Administration (USFDA) Tentative Approval for Bimatoprost Ophthalmic Solution, 0.03%.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

672.95 26.70 (4.13%)
24-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.80
Dr. Reddys Lab 1259.60
Cipla 1219.30
Zydus Lifesciences 886.50
Lupin 2331.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×